newsfilter
← Latest News
GlobeNewswire·

Kyverna Therapeutics Names Greg Martini as Chief Financial Officer

EMERYVILLE, Calif., May 18, 2026 (GLOBE NEWSWIRE) -- Kyverna Therapeutics, Inc. (NASDAQ:KYTX), a late-stage clinical biopharmaceutical company developing cell therapies for patients with autoimmune diseases, today